Date post: | 13-Apr-2015 |
Category: |
Documents |
Upload: | pai-millado |
View: | 241 times |
Download: | 5 times |
ABO BLOOD GROUP
History: Karl Landsteiner
• He and his five co-workers began mixing each others red cells and serum together and inadvertently performed the
http://www.nobelpreis.org/castellano/medizin/images/landsteiner.jpg
Why is it important?
ABO ANTIGENS
Biochemical & Genetic Considerations
ABO INHERITANCE
• In 1924, Bernstein described the theory for the
inheritance of ABO blood groups
• Codominant in expression
• Genotypes:
• Phenotypes:
ABO and H Antigen Genetics
• Genes at three separate loci (ABO, Hh, and Se)
control the occurrence and location of ABO
antigens
• There are three common alleles at the ABO
• The H and Se (secretor) loci,
• The presence or absence of the A, B, and H
antigens is controlled
Location
• The presence or absence of
the ABH antigens on the red
blood cell membrane is
controlled by the
• The presence or absence of
the ABH antigens in secretions
is indirectly controlled by the
ABO Antigen Genetics
• H gene –
• Se gene –
• ABO genes –
H Antigen
• The H gene codes for an enzyme that adds the
sugar fucose to the terminal sugar of a
• The precursor substance (proteins and lipids) is
formed on an
RBC Precursor Structure
Glucose
Galactose
N-acetylglucosamine
Galactose
Precursor
Substance
(stays the
same)
RBC
Formation of the H antigen
Glucose
Galactose
N-acetylglucosamine
Galactose
RBC
H antigen
• The H antigen is the foundation upon which A and B
antigens are built
• A and B genes code for enzymes that add an
immunodominant sugar to the H antigen
– ________________________are present at the
terminal ends of the chains and confer the ABO
antigen specificity
A and B Antigen
• The “A” gene codes for an enzyme (transferase)
that adds _______________________to the
terminal sugar of the H antigen
– N-acetylgalactosaminyltransferase
• The “B” gene codes for an enzyme that adds
________________to the terminal sugar of the
H antigen
– D-galactosyltransferase
Formation of the A antigen
Glucose
Galactose
N-acetylglucosamine
Galactose
RBC
Fucose
Formation of the B antigen
Glucose
Galactose
N-acetylglucosamine
Galactose
RBC
Fucose
Genetics
• The _____________ is found on the RBC when you
have the Hh or HH genotype, but NOT from the hh
genotype
• The _____________is found on the RBC when you have
the Hh, HH, and A/A, A/O, or A/B genotypes
• The _____________is found on the RBC when you have
the Hh, HH, and B/B, B/O, or A/B genotypes
H antigen
• Certain blood types possess more H
antigen than others:
Greatest
amount of H
Least
amount of H
ABO Antigens in Secretions
• Secretions include
• Blood Group Substances are soluble
antigens (A, B, and H) that can be found in
the secretions. This is controlled by the
Secretor Status
• The secretor gene consists of 2 alleles (Se and se)
• The Se gene is responsible for the
• If the Se allele is inherited as SeSe or Sese, the person
is called a
– 80% of the population are secretors
Secretors
• Secretors express soluble forms of the H antigen in secretions that can then be
• Individuals who inherit the sese gene are called
– The se allele is an amorph (nothing expressed)
– sese individuals do not convert antigen precursors to H antigen and has neither soluble H antigen nor soluble A or B antigens in body fluids
Secretor Status Summary
• The Se gene codes for the presence of the H antigen in
secretions, therefore the presence of A and/or B antigens
in the secretions is contingent on the inheritance of the Se
gene and the H gene
Se gene
(SeSe or Sese)
H antigen in
secretions
A antigen
B antigen
se gene
(sese)
No antigens secreted
in saliva or other
body fluids
and/or
ABO Group ABH
Substances
Secretors (SeSe or Sese): A B H
A +++ 0 +
B 0 +++ +
O 0 0 +++
AB +++ +++ +
Non-secretors (sese):
A, B, O, and AB 0 0 0
Sese + h/h (no H
antigen) no antigens
in secretions
COMPARISON OF ABH ANTIGENS
ON RBCs AND IN SECRETIONS
ABH Antigens on Red Cells A, B, and H Soluble substances
RBC antigens can be glycolipids,
glycoproteins, or glycosphingolipids
Secreted substances are glycoproteins
RBC antigens are only synthesized on type
2 precursor chains
Secreted substances are primarily
synthesized on type 1 precursor chains
Type 2 chain refers to a beta1 4 linkage
in which the number one carbon of the
galactose is attached to the number three
carbon of the N-acetylglucosamine sugar
of the precursor substance
Type 1 chain refers to a beta 1 3 linkage
in which the number one carbon of the
galactose is attached to the number three
carbon of the N-acetylglucosamine sugar
of the precursor substance
Enzyme produced by the H gene (α-2-L-fucosyltransferase)acts primarily on type 2 chains, which are prevalent on the RBC membrane
Enzyme produced by the Se gene (α-2-L-fucosyltransferase) preferentially acts on
type 1 chains in secretory tissues
Lewis (Le)
• The Lewis Blood Group System is mentioned here
because it is related to secretor status
• Lewis antigens are plasma antigens formed by tissues
and are released into plasma where they adsorb onto
the RBCs (they are not an integral part of the RBC
membrane)
• Consists of 2 antigens
– Lea
– Leb
Lewis
• Lea and Leb are a single gene (Le) and its amorph (le)
– Lea is a precursor to Leb
• The Le gene codes for a transferase, which attaches L-fucose to the precursor chain to form the Lea antigen (designated Le(a+b-)
• If the H and Se genes are inherited, the Lea is converted to Leb and is designated Le(a-b+)
• In childhood, both may be on the RBC, Le(a+b+)
• If a person is lele, they will have no Lewis antigens in plasma or on red blood cells
ABO Subgroups
• ABO subgroups differ in the amount of antigen present on the red blood cell membrane
– Subgroups have less antigen
• Subgroups are the result of less effective enzymes. They are not as efficient in converting H antigens to A or B antigens (fewer antigens are present on the RBC)
• Subgroups of A are more common than subgroups of B
Subgroups of A
• The 2 principle subgroups of A are: A1 and A2
A2 Phenotype
• Why is the A2 phenotype important?
– A2 and A2B individuals may produce an anti-A1
– This may cause discrepancies when a crossmatch is done (incompatibility)
• What’s the difference between the A1 and A2 antigen?
A1 and A2 Subgroups*
Anti-A
antisera
Anti-A1
antisera
Anti-H
lectin
ABO
antibodies
in serum
# of
antigen
sites per
RBC
A1 4+ 4+ 0 Anti-B 900 x103
A2 4+ 0 3+ Anti-B &
anti-A1
250 x103
*Adapted from Flynn, J. (1998). Essentials of Immunohematology
Other A subgroups
• There are other additional subgroups of A
– Aint (intermediate), A3, Ax, Am, Aend, Ael, Abantu
• A3 red cells cause mixed field agglutination when
polyclonal anti-A or anti-A,B is used
• Mixed field agglutination appears as small agglutinates
with a background of unagglutinated RBCs
• They may contain anti-A1
B Subgroups
• B subgroups occur less than A subgroups
• B subgroups are differentiated by the type
of reaction with anti-B, anti-A,B, and anti-H
• B3, Bx, Bm, and Bel
Other ABO conditions
• Bombay Phenotype (Oh)
• Inheritance of hh
• The h gene is an amorph and results in little or no production of L-fucosyltransferase
• Originally found in Bombay (now Mumbai)
• Very rare (130 worldwide)
Bombay (Oh) Phenotype
• Total Lack of H, A, and B antigens
• Develop strong anti-H, anti-A, and anti-B
• “O” forward, “O” reverse; with positive antibody
screen
GENERAL CHARACTERISTICS OF
BOMBAY Oh+ (Hnull) Phenotypes
• Absence of H, A, and, B antigens; no agglutination with anti-A,-B, -H
lectin
• Presence of anti-A, anti-B, and anti-A,B and a potent wide thermal
range of anti-H lectin
• A,B,H nonsecretor (no A, B, or H substances present in saliva)
• Absence of α-L-fucosyltransferase (H enzyme) in serum and H antigen on red cells
• Presence of A or B enzymes in serum (depending on ABO genotype)
• A recessive mode of inheritance (identical phenotypes in children but not in parents)
• RBCs of the Bombay phenotype will not react with the anti-H lectin
• RBCs of the Bombay phenotype are compatible only with the serum from another individual
H deficient phenotypes
• Basic Concepts
– Rare phenotypes in which the RBCs are completely
devoid of H antigens or that have small amounts of H
antigen present
– Three categories:
1) Category 1:
2) Category 2:
3) Category 3:
CLASSIFI-
CATION
Proposed
Genes
inherited
Glycosyl-
transferase
Red Cell
antigens: A,
B, and H
detected
A, B, and H
soluble
substances
in secretions
Antibodies in
serum
Category 1
Oh, OhB, Oh
A,
OhAB
hh sese None or A
and/or B in
serum or
RBC stroma
None
detectable
None
detectable
Anti-A, anti-
B, anti-H
Category 2
Oh, Ah, Bh,
ABh
A and/or B
hh sese
A and/or B in
serum and
RBC stroma
Weak A/B
Residual H
when A or B
immunodomi
nant sugar is
removed
with
appropriate
enzyme
None
detectable
Anti-H, Anti-
A/Anti-B
Category 3
OhO, Oh
A, OhB,
OhAB
Se A and/or B in
serum/
RBCs, H in
serum
(weak)
Weak A/B
and H
H substance
(normal
amounts)
A/B (all
normal
amounts)
Weak IH
Anti-A/anti-B
ABO DISCREPANCIES
• Group I
• Group II
• Group III
• Group IV
***Assignment: Resolution of the different group
discrepancies (1/2 crosswise)
GROUP I DISCREPANCIES
• Unexpected reactions in reverse grouping due to weakly reacting or
missing antibodies
• More common than most of the other groups
• Suspected when reaction in the serum grouping is weak or missing
• Reason: Patient has depressed antibody production or cannot
produce ABO antibodies
• Rare group I discrepancies: Chimerism: presence of two cell
populations in a single individual
GROUP I DISCREPANCIES
• Some of the more common populations with discrepancies in
this group are:
– Newborns
– Elderly patients
– Patients with leukemias demonstrating hypogammaglobulinemia or
lymphomas
– Patients using immunosuppressive drugs that yield
hypogammaglobulinemia
– Patients with congenital agammaglobulinemia or immunodeficiency
diseases
– Patients with bone marrow transplantations
– Patients whose existing ABO antibodies may have been diluted by
plasma transfusion or exchange
– ABO subgroups
GROUP II
DISCREPANCIES • Unexpected reactions in the forward grouping due to
weakly reacting or missing antigens
• Least frequently encountered
• Some of the causes are: – Subgroup of A (or B) may be present
– Leukemias may yield weakened A or B antigens
– Hodgkin’s disease has been reported in some cases to mimic the
depression of antigens found in leukemia
– Acquired B phenomenon is most often associated with diseases of the
digestive tract ( cancer of the colon)
GROUP II
DISCREPANCIES
• Rare Group II discrepancies
– Excess amounts of Blood group-specific soluble
(BGSS) substances present in the plasma in
association with certain diseases such as carcinoma
of the stomach and pancreas
– Antibodies to low-incidence antigens in reagent anti-A
or anti-B
– Chimerism
GROUP III
DISCREPANCIES • Between forward and reverse grouping caused by protein or
plasma abnormalities and result in roleaux formation or
pseudoagglutination attributable to:
– Elevated levels of globulin from certain disease states (MM,
Waldenstrom’s macroglobulinemia, plasma cell dyscrasias,
moderately advanced cases of Hodgkin’s lymphomas)
– Elevated levels of fibrinogen
– Plasma expanders (dextran and polyvinylpyrrolidone)
– Wharton’s jelly in cord blood samples
GROUP IV
DISCREPANCIES • Between forward and reverse groupings due to
miscellaneous problems and have the following :
– Cold reactive autoantibodies in which RBCs are so heavily
coated with antibody that they spontaneously agglutinate,
independent of the specificity of the reagent antibody
– Patient has circulating RBCs of more than one ABO group due
to RBC transfusion or marrow transplant
– Unexpected ABO isoagglutinins
– Unexpected non-ABO alloantibodies
GROUP IV
DISCREPANCIES
• Rare Group IV discrepancies
– Antibodies other than anti-A or anti-B may react to
form ag-ab complexes that may then adsorb onto
patient’s RBCs
– Some individuals have antibodies against acriflavin in
their serum
• Px’s ab combines with the dye and attaches to the px’s rbcs,
resulting in agglutination in the forward grouping
ABO Blood Group:
ABO Antibodies
Landsteiner’s Rule:
• Normal, Healthy
individuals possess
ABO antibodies to
the ABO antigen
absent from their
RBCs
ABO Blood Group System
• The ABO Blood Group System was the first to be
identified and is the most significant for transfusion
practice
• It is the ONLY system that the reciprocal antibodies are
consistently and predictably present in the sera of people
who have had no exposure to human red cells
Blood Group Systems
• Most blood group systems (ABO and others) are made up of:
– An antigen on a red cell and the absence of it’s corresponding antibody in the serum (if you’re A, you don’t have anti-A)
• If you do NOT have a particular antigen on your red cells then it is possible (when exposed to foreign RBCs) to illicit an immune response that results in the production of the antibody specific for the missing antigen
ABO
• Remember:
– The ABO Blood Group System does NOT
require the presence of a foreign red blood
cell for the production of ABO antibodies
– ABO antibodies are “non-red blood cell
stimulated” probably from environmental
exposure and are referred to as “expected
antibodies”
ABO antibodies
• group A serum contains anti-B
• group B serum contains anti-A
• group AB serum contains no antibodies
• group O serum contains anti-A, anti-B, and
anti-A,B
Anti-A1
• Group O and B individuals contain anti-A in their
serum
• However, the anti-A can be separated into
different components: anti-A and anti-A1
Anti-A,B
• Found in the serum of group O individuals
• Reacts with A, B, and AB cells
• Predominately IgG, with small portions
being IgM
• Anti-A,B is one antibody, it is not a mixture
of anti-A and anti-B antibodies
ABO antibodies
• Activate complement
• React at room temperature or colder
• IgM is the predominant antibody in Group A and Group B
individuals
• IgG (with some IgM) is the predominant antibody in
Group O individuals
ABO antibody facts
• Reactions phase:
• Complement can be activated with ABO
antibodies (mostly IgM, some IgG)
• High titer:
ABO Antibodies
• Usually present within the first 3-6 months of life
• Stable by ages 5-6 years
• Decline in older age
• Newborns may passively acquire maternal antibodies
(IgG crosses placenta)
– Reverse grouping (with serum) should not be
performed on newborns or cord blood
Nature of antibodies
• Non-red blood cell stimulated (previously discussed)
– ABO antibodies
• Red blood cell stimulated
– Antibodies formed as a result of transfusion, etc
– Usually IgG
– Active at 37°C
– Can occur in group O (may occur in group A or B)
– These antibodies also occur in the other Blood Group Systems
Laboratory Testing:
ABO typing
The Use of Lectins for Antigen
Confirmation
• Dolichos biflorus = anti-A1
• Ulex europaeus = anti-H
58
ABO Blood Groups
ABO
Group
Antigen
Present
Antigen
Missing
Antibody
Present
A A B anti-B
B B A anti-A
O None A and B anti-A, anti-B, anti-A,B
AB A and B None None
Forward & Reverse Typing
anti-A anti-B A cells B cells ABO
group
1 0 0 + + O
2 + 0 0 + A
3 0 + + 0 B
4 + + 0 0 AB
Reaction of cells
tested with:
Reaction of serum
tested with:
ABO Ag LOCATION IN THE
BODY
• Body fluids
– Saliva
– Tears
– Urine
– Digestive juices
– Bile
– Milk
– Amniotic fluid
• Pathologic fluids
– Pleural
– Peritoneal
– Pericardial
– Ovarian cyst
ABO Antigens and Antibodies
• ABO antigens based on combinations of three genes: A,
B, and O
• Antibodies are clinically significant and “naturally
occurring”
– causing most fatal acute HTRs
– some causing HDFN
• ABO antibodies neutralized with secretor saliva.
Group O
• Generally the most common blood group
• Genotype: OO
• Antigen: H
• Antibodies: anti-A, anti-B, and anti-A,B
– Antibodies are naturally occurring and very strong
– Anti-A,B (mostly IgG) may cross placenta to cause
HDFN
Group A
• Genotype:
• Antigen:
• Antibodies:
• A subgroups
Group B
• Genotype:
• Antigen:
• Antibodies:
• B subgroups: Not important
Group AB
• Genotype:
• Antigen:
• Antibodies:
• B subgroups: Not important
• A2B:
ABO Testing
• Cell typing (forward grouping) to determine antigen
types on RBCs
• Serum/plasma typing (reverse grouping or
backtyping) to determine type of antibody in serum:
• Note the opposite reactions
– If the forward reactions are opposite of reverse, an
ABO discrepancy is not present.
ABO Grouping Reagents
• Forward Grouping Reagent
• Reverse or Back Tying Cells
Forward Grouping Reagent
Forward Grouping
• Reagent: Monoclonal antibody
– Highly specific
– IgM
– Expected 3+- to 4+ reaction
– 1 drop
– Anti-A=Blue; anti-B=Yellow (Acroflavin dye)
• A and B antigens on patient red cells are agglutinated by known sera (anti-A, anti-B)
Reverse or Back Tying
Reagent Cells
Reverse or Back Typing
• Reagent Cells: Human Source
– Expected 2+ to 4+ reaction
– 4-5% cell suspension
– 1 drop
• Anti-A or anti-B antibodies in patient serum (or plasma)
agglutinate with A1 and B antigens on Reagent cells
Forward Typing Procedures
• To determine what antigens are present
on RBCs.
Step 1. Label test tubes.
Step 2: Make a 2-5%
patient red cell suspension.
Step 3: Add reagent
antisera (1 drop).
Step 3A: Add reagent Anti-A antisera
(1 drop).
Step 3B: Add Anti-B reagent antisera
(1 drop).
Step 4: Add one drop of 2-5% suspension
of patient RBC to each tube.
80
Step 5: Mix and centrifuge
(approximately 20 seconds).
Group A: 4+ Agglutination with Anti-A
0 Agglutination with Anti-B
Group B: 4+ Agglutination with Anti-B
0 Agglutination with Anti-A
Group AB: 4+ Agglutination with Anti-A
and Anti-B
Group O:
No Agglutination with Anti-A or Anti-B
Back Typing
• To determine what antibodies are present
in patient’s plasma.
Step 1: Label Test Tubes
Step 2: Add two drops of
patient serum to each tube
Step 3: Add one drop of
reagent cells to each test tube
Step 3A: Add one drop of
Reagent A1 cells
Step 3B: Add one drop of
Reagent B cells
Step 4: Mix and centrifuge
(approximately 20 seconds)
Group A: 4+ Agglutination with B Cells
0 Agglutination with A1 Cells
Group B: 4+ Agglutination with A1 Cells
0 Agglutination with B Cells
Group O: 4+ Agglutination with A1 Cells
3+ Agglutination with B Cells
Group AB:
No Agglutination with A1 and B Cells
What can Cause ABO
Discrepancies?
• Disagreement between the
interpretations of forward and
reverse grouping
• Antigen problems
• Antibody problems
Antigen Problems
• Lack of expected antigens
• Presence of unexpected antigens
Antibody problems
• Lack of expected antibodies
• Presence of unexpected antibodies
A Subgroups
• A1
• A2
• A3
• Ax
• Aend
• Am
• etc
A1 vs A2 Phenotypes
Blood Group Anti-A Anti-A1 lectin
A1 (80%) + +
A2 (20%) + 0
• A1 & A2 account for 99% of A group
A1vs A2 Phenotypes
• Quantitative differences:
• Qualitative differences between A1 and
A2 antigens:
B Subgroups
• Very rare and are less frequent than A
subgroups.
• B subgroups demonstrate variations in
the strength of the reaction using anti-
B and anti-A,B
• Examples are: B3, Bx, Bm, Bel
Acquired B phenotype
• Occurs in type A individuals with:
• Bacteria deacetylate group A sugar
(GalNAc); remaining galactosamine
crossreacts with reagent anti-B.
Acquired B phenotype
Acquired B phenotype
• AB forward (with weak reactions with
reagent anti-B)
• A reverse
• Reaction with anti-B is negative, if:
Acquired B typing result
Forward Reverse
Anti-A Anti-B Interp A1 cells B cells Interp
4+ 1-2+ AB 0 4+ A”B”
Blood Type:
Antigens vs Antibodies
Blood Type Antigens Antibodies
on rbcs in Plasma
A A Anti-B
B B Anti-A
AB A,B None
O None Anti-A, Anti-B
Consequences of
ABO incompatibility
• Severe acute hemolytic transfusion
reactions
– One of the most frequent causes of blood
bank fatalities
– Clerical errors
• Most frequent HDFN; usually mild.
Sources of Technical Errors
Resulting in ABO Discrepancies
• Inadequate identification of blood samples
• Cell suspension too heavy or too light
• Clerical errors
• A mix-up in samples
• Missed observation of hemolysis
• Failure to add reagents
• Failure to follow manufacturer’s instructions
• Uncalibrated centrifuge
• Contaminated reagents
• Warming during centrifugation
Resolving ABO
Discrepancies
Problems with RBCs Resolution Techniques
Rouleaux
MF agglutination
Unusual phenotype (hh)
Disease processes (Acq. B)
Resolving ABO
Discrepancies (Cont’d) Problems with serum Resolution Techniques
Rouleaux
Presence of unexpected Ab
Absence of expected Ab